These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23273567)

  • 1. Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia.
    Below JE; Earl DL; Shively KM; McMillin MJ; Smith JD; Turner EH; Stephan MJ; Al-Gazali LI; Hertecant JL; Chitayat D; Unger S; Cohn DH; Krakow D; Swanson JM; Faustman EM; Shendure J; Nickerson DA; Bamshad MJ;
    Am J Hum Genet; 2013 Jan; 92(1):137-43. PubMed ID: 23273567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia.
    Iida A; Okamoto N; Miyake N; Nishimura G; Minami S; Sugimoto T; Nakashima M; Tsurusaki Y; Saitsu H; Shiina M; Ogata K; Watanabe S; Ohashi H; Matsumoto N; Ikegawa S
    J Hum Genet; 2013 Jun; 58(6):391-4. PubMed ID: 23552673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia.
    Huber C; Faqeih EA; Bartholdi D; Bole-Feysot C; Borochowitz Z; Cavalcanti DP; Frigo A; Nitschke P; Roume J; Santos HG; Shalev SA; Superti-Furga A; Delezoide AL; Le Merrer M; Munnich A; Cormier-Daire V
    Am J Hum Genet; 2013 Jan; 92(1):144-9. PubMed ID: 23273569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INPPL1 gene mutations in opsismodysplasia.
    Fradet A; Fitzgerald J
    J Hum Genet; 2017 Feb; 62(2):135-140. PubMed ID: 27708270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second locus for Schneckenbecken dysplasia identified by a mutation in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1).
    Lee H; Nevarez L; Lachman RS; Wilcox WR; Krakow D; Cohn DH;
    Am J Med Genet A; 2015 Oct; 167A(10):2470-3. PubMed ID: 25997753
    [No Abstract]   [Full Text] [Related]  

  • 6. Opsismodysplasia resulting from an insertion mutation in the SH2 domain, which destabilizes INPPL1.
    Li B; Krakow D; Nickerson DA; Bamshad MJ; ; Chang Y; Lachman RS; Yilmaz A; Kayserili H; Cohn DH
    Am J Med Genet A; 2014 Sep; 164A(9):2407-11. PubMed ID: 24953221
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia.
    Feist C; Holden P; Fitzgerald J
    Clin Dysmorphol; 2016 Oct; 25(4):152-5. PubMed ID: 27233067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association analysis of inositol polyphosphate phosphatase-like 1 (INPPL1, SHIP2) variants with essential hypertension.
    Marçano AC; Burke B; Gungadoo J; Wallace C; Kaisaki PJ; Woon PY; Farrall M; Clayton D; Brown M; Dominiczak A; Connell JM; Webster J; Lathrop M; Caulfield M; Samani N; Gauguier D; Munroe PB
    J Med Genet; 2007 Sep; 44(9):603-5. PubMed ID: 17557929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia.
    Vande Catsyne CA; Sayyed SA; Molina-Ortiz P; Moes B; Communi D; Muller J; Heusschen R; Caers J; Azzi A; Erneux C; Schurmans S
    Adv Biol Regul; 2020 May; 76():100651. PubMed ID: 31519471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy.
    Khwaja A; Parnell SE; Ness K; Bompadre V; White KK
    Front Pediatr; 2015; 3():48. PubMed ID: 26157786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects.
    Ghosh S; Huber C; Siour Q; Sousa SB; Wright M; Cormier-Daire V; Erneux C
    Hum Mutat; 2017 Dec; 38(12):1731-1739. PubMed ID: 28869677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diversity and possible functions of the inositol polyphosphate 5-phosphatases.
    Erneux C; Govaerts C; Communi D; Pesesse X
    Biochim Biophys Acta; 1998 Dec; 1436(1-2):185-99. PubMed ID: 9838104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
    Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
    FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome.
    Kaisaki PJ; Delépine M; Woon PY; Sebag-Montefiore L; Wilder SP; Menzel S; Vionnet N; Marion E; Riveline JP; Charpentier G; Schurmans S; Levy JC; Lathrop M; Farrall M; Gauguier D
    Diabetes; 2004 Jul; 53(7):1900-4. PubMed ID: 15220217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
    Astle MV; Horan KA; Ooms LM; Mitchell CA
    Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
    Eramo MJ; Mitchell CA
    Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ABL1 fusion to the SH2 containing inositol phosphatase-1 (SHIP1) in acute lymphoblastic leukemia (ALL).
    Kakadia PM; Tizazu B; Mellert G; Harbott J; Röttgers S; Quentmeier H; Spiekermann K; Bohlander SK
    Leukemia; 2011 Oct; 25(10):1645-9. PubMed ID: 21625237
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.
    Sleeman MW; Wortley KE; Lai KM; Gowen LC; Kintner J; Kline WO; Garcia K; Stitt TN; Yancopoulos GD; Wiegand SJ; Glass DJ
    Nat Med; 2005 Feb; 11(2):199-205. PubMed ID: 15654325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
    Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
    Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.